This Former Hockey Player Is Betting Glucose Monitoring Will Change How People Think About Their Weight

"Sharam Fouladgar-Mercer always struggled with his weight. Even as a Division I hockey player at Princeton, he noticed his teammates could eat 5,000 calories a day without gaining a pound while he struggled on far less. Same diet, same exercise, completely different results. The math never added up. He spent years yo-yoing back and forth - losing the weight, gaining it back, losing it again. The cycle was exhausting and, more than anything, confusing."

""Why are we waiting until people have a chronic care condition before enabling them to learn from their own body's natural signals?" That question became Signos - the first FDA-cleared glucose monitoring platform for weight management. The company has grown more than 10x in the last six months, positioning itself as a tool for anyone serious about understanding their own metabolism - including the tens of thousands coming off GLP-1 medications every day who need a new plan."

"Fouladgar-Mercer didn't just build the product. He became its first customer, losing 40 pounds using it himself. Then he did something most founders wouldn't consider: once he'd maintained that weight loss for a while, he realized he could no longer evaluate whether the app's features made sense for someone actively trying to lose weight. So he intentionally gained it back to test the product again. Medical professionals had already told him the whole idea was "dumb." He kept going anyway."

Sharam Fouladgar-Mercer experienced persistent weight struggles despite athletic background, leading to years of yo-yo dieting. A 2018 encounter with a friend's continuous glucose monitor revealed actionable metabolic signals. That insight led to Signos, an FDA-cleared glucose monitoring platform for weight management that pairs CGM technology with AI. The company scaled more than tenfold in six months and targets people seeking metabolic understanding, including those transitioning off GLP-1 medications. Fouladgar-Mercer became the first customer, lost 40 pounds, and intentionally regained weight to rigorously retest the product despite medical skepticism.

Read at Entrepreneur